Pancreatic Cancer Research

ResearcherTranscode Therapeutics, Inc.Active in the last 2 years

Zdravka O. Medarova

Matched on OpenAlex author ID A5013188765; NIH RePORTER profile ID 8683425. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
2
Labs led
0
Collaborators
7
Papers, trials and grants by year

2011: 1 grant · 2012: none · 2013: none · 2014: none · 2015: none · 2016: 2 papers · 2017: none · 2018: none · 2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 grant

Papers 3

  1. RNAi-Mediated PD-L1 Inhibition for Pancreatic Cancer Immunotherapy. Last author DOI 10.1038/s41598-019-41251-9↗
  2. Predictive imaging of chemotherapeutic response in a transgenic mouse model of pancreatic cancer. Co-author DOI 10.1002/ijc.30098↗
  3. Presentation of underglycosylated mucin 1 in pancreatic adenocarcinoma (PDAC) at early stages. Co-author PMID 27725904↗

Grants 2

  1. Phase I Clinical Testing of a First-in-Class Therapy against Metastatic Cancer R44CA295173↗
  2. Multi-Parameter Monitoring of Breast Cancer Progression and Therapeutic Response R01CA135650↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Anna V. Moore · 2 shared papers, 1 shared grant, 2011–2016 · strength 0.25
  2. Byunghee Yoo · 2 shared papers, 2016–2019 · strength 0.16
  3. Veronica Clavijo Jordan · 1 shared paper, 2019 · strength 0.11
  4. Su‐Tang Lo · 1 shared paper, 2016 · strength 0.08
  5. Christian T. Farrar · 1 shared paper, 2016 · strength 0.06
  6. Ping Wang · 1 shared paper, 2016 · strength 0.06
  7. Pinku Mukherjee · 1 shared paper, 2016 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.